AIDS and Behavior

, Volume 13, Issue 1, pp 60–65

Gender and Other Psychosocial Factors as Predictors of Adherence to Highly Active Antiretroviral Therapy (HAART) in Adults with Comorbid HIV/AIDS, Psychiatric and Substance-related Disorder

  • Allison J. Applebaum
  • Mark A. Richardson
  • Stephen M. Brady
  • Deborah J. Brief
  • Terence M. Keane
Report

Abstract

This study assessed adherence to HAART among 67 HIV-infected adults, and the degree to which gender and psychological factors—including depression, drug and alcohol use, quality of life, and medication side effects—influenced adherence. Although overall adherence was greater than rates reported in similar studies, no significant difference in adherence was observed between men and women in the present sample. Medication side effects were a significant predictor of non-adherence in the sample at large and among women in particular, while alcohol dependence was a significant predictor of non-adherence only in women. Possible explanations are explored.

Keywords

Adherence HIV/AIDS Gender HAART 

References

  1. Berg, K., Demas, P., Howard, A., Schoenbaum, E., Gourevitch, M., & Arnsten, J. (2004). Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19, 1111–1117. doi:10.1111/j.1525-1497.2004.30445.x.PubMedCrossRefGoogle Scholar
  2. Carrieri, M., Spire, B., Duran, S., Katlama, C., Peyramond, D., Francois, C., et al. (2003). Health-related quality of life after 1 year of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 32, 38–47.PubMedGoogle Scholar
  3. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwicks, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care, 12, 255–266. doi:10.1080/09540120050042891.PubMedCrossRefGoogle Scholar
  4. Cook, J., Cohen, M., Burke, J., Grey, D., Anastos, K., Kirstein, L., et al. (2002). Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. Journal of Acquired Immune Deficiency Syndromes, 30, 401–409. doi:10.1097/01.qai.0000018280.16783.fe.PubMedGoogle Scholar
  5. Cook, J., Grey, D., Burke-Miller, J., Cohen, M., Vlahov, D., Kapadia, F., et al. (2007). Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence, 89, 74–81. doi:10.1016/j.drugalcdep. 2006.12.002.PubMedCrossRefGoogle Scholar
  6. Haug, N., Sorensen, J., Lllo, N., Gruber, V., Delucchi, K., & Hall, S. (2005). Gender differences among HIV- positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care, 17, 1022–1029. doi:10.1080/09540120500100882.PubMedCrossRefGoogle Scholar
  7. HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. (2004). The HIV/AIDS Treatment Adherence. Health Outcomes and Cost Study: Conceptual foundations and overview. AIDS Care, 16(Suppl. 1), S6–S21. doi:10.1080/09540120412331315312.Google Scholar
  8. Johnston, R., & Mann, T. (2000). Barriers to antiretroviral medication adherence in HIV infected women. AIDS Care, 12, 377–386. doi:10.1080/09540120050123774.CrossRefGoogle Scholar
  9. Shor-Posner, G., Lecusay, R., Miguez-Burbano, M., Quesada, J., Rodriguez, A., Ruiz, P., et al. (2000). Quality of life measures in the Miami HIV-infected drug abusers cohort: Relationship to gender and disease status. Journal of Substance Abuse, 11, 395–404. doi:10.1016/S0899-3289(00)00035-3.PubMedCrossRefGoogle Scholar
  10. Turner, B., Laine, C., Cosler, L., & Hauch, W. (2003). Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal of General Internal Medicine, 18, 248–257. doi:10.1046/j.1525-1497.2003.20122.x.PubMedCrossRefGoogle Scholar
  11. Uldall, K., Palmer, N., Whetten, K., & HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group. (2004). Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: A review of the literature. AIDS Care, 16(Suppl. 1), S71–S96. doi:10.1080/09540120412331315277.PubMedCrossRefGoogle Scholar
  12. Ware, J., Kosinski, M., Bayliss, M., McHorney, C., Rogers, W., & Raczek, A. (1995). Comparison on methods for the scoring and statistical analysis of SF-36 Health Profile and Summary Measures. Summary of results from the Medical Outcomes Study. Medical Care, 33, AS264–AS279. doi:10.1097/00005650-199501001-00005.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Allison J. Applebaum
    • 1
  • Mark A. Richardson
    • 1
    • 2
  • Stephen M. Brady
    • 2
  • Deborah J. Brief
    • 2
    • 3
  • Terence M. Keane
    • 1
    • 2
    • 4
  1. 1.Department of PsychologyBoston UniversityBostonUSA
  2. 2.Division of PsychiatryBoston University School of MedicineBostonUSA
  3. 3.Department of PsychologyVA Boston Healthcare SystemBostonUSA
  4. 4.Research ServiceVA Boston Healthcare SystemBostonUSA

Personalised recommendations